These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 3293334)

  • 1. Purification of Clostridium botulinum type G progenitor toxin.
    Nukina M; Mochida Y; Sakaguchi S; Sakaguchi G
    Zentralbl Bakteriol Mikrobiol Hyg A; 1988 Apr; 268(2):220-7. PubMed ID: 3293334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification and properties of Clostridium botulinum type F toxin.
    Yang KH; Sugiyama H
    Appl Microbiol; 1975 May; 29(5):598-603. PubMed ID: 807160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid method for purification of Clostridium botulinum type C neurotoxin by high performance liquid chromatography (HPLC).
    Matsuda M; Ozutsumi K; Du PY; Sugimoto N
    Eur J Epidemiol; 1986 Dec; 2(4):265-71. PubMed ID: 3542554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization of culture conditions for toxin production of type G Clostridium botulinum.
    Calleri de Milan MC; Mayorga LS; Puig de Centorbi ON
    Zentralbl Bakteriol; 1992 Jul; 277(2):161-9. PubMed ID: 1520974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification of Clostridium botuliunum type F progenitor toxin.
    Oishi I; Sakaguchi G
    Appl Microbiol; 1974 Dec; 28(6):923-8. PubMed ID: 4615636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of Clostridium botulinum type E toxin purified by two different procedures.
    Yokosawa N; Tsuzuki K; Syuto B; Oguma K
    J Gen Microbiol; 1986 Jul; 132(7):1981-8. PubMed ID: 2432159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification and some properties of progenitor toxins of Clostridium botulinum type B.
    Kozaki S; Sakaguchi S; Sakaguchi G
    Infect Immun; 1974 Oct; 10(4):750-6. PubMed ID: 4214781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification and characterization of two components of botulinum C2 toxin.
    Ohishi I; Iwasaki M; Sakaguchi G
    Infect Immun; 1980 Dec; 30(3):668-73. PubMed ID: 6785232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simplified purification method for Clostridium botulinum type E toxin.
    Giménez JA; Sugiyama H
    Appl Environ Microbiol; 1987 Dec; 53(12):2827-30. PubMed ID: 3435146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COMPARATIVE GEL FILTRATION OF TOXIN PRECURSOR AND TRYPSIN-ACTIVATED TOXIN OF CLOSTRIDIUM BOTULINUM TYPE E.
    SAKAGUCHI G; SAKAGUCHI S; IMAI N
    J Bacteriol; 1964 Feb; 87(2):401-7. PubMed ID: 14151063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of Clostridium botulinum type B toxin by an endogenous enzyme.
    DasGupta BR
    J Bacteriol; 1971 Dec; 108(3):1051-7. PubMed ID: 4945183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of fermentation conditions on toxin production by Clostridium botulinum type B.
    Siegel LS; Metzger JF
    Appl Environ Microbiol; 1980 Dec; 40(6):1023-6. PubMed ID: 7006503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of botulinum toxins in the absence of nicking.
    Ohishi I; Sakaguchi G
    Infect Immun; 1977 Aug; 17(2):402-7. PubMed ID: 19360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxin production by Clostridium botulinum type A under various fermentation conditions.
    Siegel LS; Metzger JF
    Appl Environ Microbiol; 1979 Oct; 38(4):606-11. PubMed ID: 44175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clostridium botulinum type C produces a novel ADP-ribosyltransferase distinct from botulinum C2 toxin.
    Aktories K; Weller U; Chhatwal GS
    FEBS Lett; 1987 Feb; 212(1):109-13. PubMed ID: 3100333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clostridium botulinum type E toxin: effect of pH and method of purification on molecular weight.
    Sacks HS; Covert SV
    Appl Microbiol; 1974 Sep; 28(3):374-82. PubMed ID: 4609265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Difficulties of molecular dissociation of Clostridium botulinum type G progenitor toxin.
    Nukina M; Mochida Y; Sakaguchi S; Sakaguchi G
    FEMS Microbiol Lett; 1991 Apr; 63(2-3):165-70. PubMed ID: 1905655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Isolation and properties of highly purified C1. botulinum toxin type E].
    Levdikova GA; Klimacheva LV; Ispolatovskaia MV; Bulatova TI; Anisimova LI
    Biokhimiia; 1979 Aug; 44(8):1392-400. PubMed ID: 115504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production, purification, and characterization of botulinolysin, a thiol-activated hemolysin of Clostridium botulinum.
    Haque A; Sugimoto N; Horiguchi Y; Okabe T; Miyata T; Iwanaga S; Matsuda M
    Infect Immun; 1992 Jan; 60(1):71-8. PubMed ID: 1729198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response of type B and E Botulinum toxins to purified sulfhydryl-dependent protease produced by Clostridium botulinum type F.
    Ohishi I; Sakaguchi G
    Jpn J Med Sci Biol; 1977 Aug; 30(4):179-90. PubMed ID: 20527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.